Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127872) titled 'Bile lipidomics-based investigation of lipid alterations and their clinical significance in patients with cholangiocarcinoma' on July 9.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: The second hospital of Dalian Medical University

Condition: Cholangiocarcinoma

Intervention: Gold Standard:Pathology diagnosis

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-08-01

Target Sample Size: Target condition:500;Difficult condition:0

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=327808 ...